Guidelines recommend wider statin use among adults with chronic kidney disease

Date: Dec-09-2013Guidelines from the Kidney Disease: Developing Global Guidelines (KDIGO) organization call for wider statin use among patients with chronic kidney disease (CKD). KDIGO updated its clinical practice guidelines for lipid management in patients with CKD earlier in 2013. A synopsis of these guidelines being published in Annals of Internal Medicine focuses on eight specific recommendations relating to pharmacological cholesterol-lowering among adult patients with CKD.
Patients recommended for statin use include adults aged 50 or older with eGFR
Statin use is also recommended for kidney transplant recipients, as their risk for coronary events is markedly elevated.
Younger adults (18 - 49 years) with eGFR diabetes, prior ischemic stroke, or an estimated 10-year incidence of coronary death or non-fatal myocardial infarction of more than 10 percent.
Evidence suggests that LDL-C is not an adequate assessment of cardiovascular risk in people with CKD. Adults with newly identified CKD should be evaluated with a lipid profile, but follow-up measurement is not required.
The complete synopsis is available here.

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.